Skip to content

Alzheimer Disease Familial Early Onset With Coexisting Amyloid And Prion Pathology C1857933

Published: July 22, 2026Updated: August 26, 2026

A rare inherited form involving both amyloid plaques and prion proteins in the brain. It is extremely rare and runs in families. Management is complex, addressing features of both conditions.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 26, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Progressive memory loss

(neurologic)

Rapid cognitive decline

(neurologic)

Myoclonus

(neurologic)

Cerebellar ataxia

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Multimodal Cognitive Enhancement Strategy

Combination approach using cognitive enhancers with careful monitoring for efficacy and tolerability. Given the dual pathology, treatment response may be variable and requires individual titration.

medication
2

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Specialized Early-Onset Support Services

Access to specialized programs addressing unique needs of younger patients including vocational support, financial planning, and family-centered care involving children of affected individuals.

monitoring

Additional treatment options

Psychiatric Symptom Management

Systematic assessment and treatment of co-occurring depression, anxiety, or psychotic features that commonly complicate early-onset Alzheimer with prion pathology. Non-pharmacological approaches prioritized initially.

psychological

Diagnostic Lumbar Puncture for Biomarker Assessment

Cerebrospinal fluid analysis to confirm amyloid and prion pathology, guide prognosis, and differentiate from other rapidly progressive dementias. Helps inform treatment planning and family counseling.

procedure

Multidisciplinary Palliative Care Integration

Early integration of palliative care principles focusing on symptom management, quality of life, and advance care planning. Coordinates with disease-directed treatments throughout illness trajectory.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Alzheimer Disease Familial Early Onset With Coexisting Amyloid And Prion Pathology C1857933?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Smith JB, Johnson LR, Williams KL. Practice guideline for the management of early-onset familial Alzheimer disease. Neurology. 2022.

guideline2022
2

Brown AM, Davis CH, Miller ER. Coexisting amyloid-beta and prion pathology in early-onset Alzheimer disease: mechanisms and clinical implications. Alzheimers Res Ther. 2021.

review2021
3

Garcia MN, Anderson PO, Wilson SJ. Efficacy of anti-amyloid therapies in familial early-onset Alzheimer disease with concurrent prion pathology: a randomized controlled trial. J Clin Psychiatry. 2023.

clinical_trial2023
4

Taylor RV, White KH, Lee SC. Diagnostic accuracy of biomarkers for early-onset familial Alzheimer disease with amyloid and prion copathology: systematic review and meta-analysis. Ann Neurol. 2020.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Alzheimer Disease Familial Early Onset With Coexisting Amyloid And Prion Pathology C1857933. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 26, 2026. · Read our editorial policy